No Cover Image

Journal article 922 views 559 downloads

Efficacy and Safety of Dapagliflozin in Patients With Inadequately Controlled Type 1 Diabetes (the DEPICT-2 Study): 24-Week Results From a Randomized Controlled Trial

Chantal Mathieu, Paresh Dandona, Pieter Gillard, Peter Senior, Christoph Hasslacher, Eiichi Araki, Marcus Lind, Stephen C. Bain, Serge Jabbour, Niki Arya, Lars Hansen, Fredrik Thorén, Anna Maria Langkilde, Steve Bain Orcid Logo

Diabetes Care, Volume: 41, Issue: 9, Pages: 1938 - 1946

Swansea University Author: Steve Bain Orcid Logo

Check full text

DOI (Published version): 10.2337/dc18-0623

Published in: Diabetes Care
ISSN: 0149-5992 1935-5548
Published: 2018
Online Access: Check full text

URI: https://cronfa.swan.ac.uk/Record/cronfa43485
Tags: Add Tag
No Tags, Be the first to tag this record!
first_indexed 2018-08-15T12:57:32Z
last_indexed 2023-01-11T14:20:06Z
id cronfa43485
recordtype SURis
fullrecord <?xml version="1.0"?><rfc1807><datestamp>2022-12-02T19:05:08.6045160</datestamp><bib-version>v2</bib-version><id>43485</id><entry>2018-08-15</entry><title>Efficacy and Safety of Dapagliflozin in Patients With Inadequately Controlled Type 1 Diabetes (the DEPICT-2 Study): 24-Week Results From a Randomized Controlled Trial</title><swanseaauthors><author><sid>5399f4c6e6a70f3608a084ddb938511a</sid><ORCID>0000-0001-8519-4964</ORCID><firstname>Steve</firstname><surname>Bain</surname><name>Steve Bain</name><active>true</active><ethesisStudent>false</ethesisStudent></author></swanseaauthors><date>2018-08-15</date><deptcode>BMS</deptcode><abstract/><type>Journal Article</type><journal>Diabetes Care</journal><volume>41</volume><journalNumber>9</journalNumber><paginationStart>1938</paginationStart><paginationEnd>1946</paginationEnd><publisher/><placeOfPublication/><isbnPrint/><isbnElectronic/><issnPrint>0149-5992</issnPrint><issnElectronic>1935-5548</issnElectronic><keywords/><publishedDay>1</publishedDay><publishedMonth>9</publishedMonth><publishedYear>2018</publishedYear><publishedDate>2018-09-01</publishedDate><doi>10.2337/dc18-0623</doi><url/><notes/><college>COLLEGE NANME</college><department>Biomedical Sciences</department><CollegeCode>COLLEGE CODE</CollegeCode><DepartmentCode>BMS</DepartmentCode><institution>Swansea University</institution><apcterm/><funders/><projectreference/><lastEdited>2022-12-02T19:05:08.6045160</lastEdited><Created>2018-08-15T09:42:47.2091930</Created><path><level id="1">Faculty of Medicine, Health and Life Sciences</level><level id="2">Swansea University Medical School - Medicine</level></path><authors><author><firstname>Chantal</firstname><surname>Mathieu</surname><order>1</order></author><author><firstname>Paresh</firstname><surname>Dandona</surname><order>2</order></author><author><firstname>Pieter</firstname><surname>Gillard</surname><order>3</order></author><author><firstname>Peter</firstname><surname>Senior</surname><order>4</order></author><author><firstname>Christoph</firstname><surname>Hasslacher</surname><order>5</order></author><author><firstname>Eiichi</firstname><surname>Araki</surname><order>6</order></author><author><firstname>Marcus</firstname><surname>Lind</surname><order>7</order></author><author><firstname>Stephen C.</firstname><surname>Bain</surname><order>8</order></author><author><firstname>Serge</firstname><surname>Jabbour</surname><order>9</order></author><author><firstname>Niki</firstname><surname>Arya</surname><order>10</order></author><author><firstname>Lars</firstname><surname>Hansen</surname><order>11</order></author><author><firstname>Fredrik</firstname><surname>Thor&#xE9;n</surname><order>12</order></author><author><firstname>Anna Maria</firstname><surname>Langkilde</surname><order>13</order></author><author><firstname>Steve</firstname><surname>Bain</surname><orcid>0000-0001-8519-4964</orcid><order>14</order></author></authors><documents><document><filename>0043485-15082018094405.pdf</filename><originalFilename>Mathieu2018.pdf</originalFilename><uploaded>2018-08-15T09:44:05.2730000</uploaded><type>Output</type><contentLength>521662</contentLength><contentType>application/pdf</contentType><version>Accepted Manuscript</version><cronfaStatus>true</cronfaStatus><embargoDate>2018-09-02T00:00:00.0000000</embargoDate><copyrightCorrect>true</copyrightCorrect><language>eng</language></document></documents><OutputDurs/></rfc1807>
spelling 2022-12-02T19:05:08.6045160 v2 43485 2018-08-15 Efficacy and Safety of Dapagliflozin in Patients With Inadequately Controlled Type 1 Diabetes (the DEPICT-2 Study): 24-Week Results From a Randomized Controlled Trial 5399f4c6e6a70f3608a084ddb938511a 0000-0001-8519-4964 Steve Bain Steve Bain true false 2018-08-15 BMS Journal Article Diabetes Care 41 9 1938 1946 0149-5992 1935-5548 1 9 2018 2018-09-01 10.2337/dc18-0623 COLLEGE NANME Biomedical Sciences COLLEGE CODE BMS Swansea University 2022-12-02T19:05:08.6045160 2018-08-15T09:42:47.2091930 Faculty of Medicine, Health and Life Sciences Swansea University Medical School - Medicine Chantal Mathieu 1 Paresh Dandona 2 Pieter Gillard 3 Peter Senior 4 Christoph Hasslacher 5 Eiichi Araki 6 Marcus Lind 7 Stephen C. Bain 8 Serge Jabbour 9 Niki Arya 10 Lars Hansen 11 Fredrik Thorén 12 Anna Maria Langkilde 13 Steve Bain 0000-0001-8519-4964 14 0043485-15082018094405.pdf Mathieu2018.pdf 2018-08-15T09:44:05.2730000 Output 521662 application/pdf Accepted Manuscript true 2018-09-02T00:00:00.0000000 true eng
title Efficacy and Safety of Dapagliflozin in Patients With Inadequately Controlled Type 1 Diabetes (the DEPICT-2 Study): 24-Week Results From a Randomized Controlled Trial
spellingShingle Efficacy and Safety of Dapagliflozin in Patients With Inadequately Controlled Type 1 Diabetes (the DEPICT-2 Study): 24-Week Results From a Randomized Controlled Trial
Steve Bain
title_short Efficacy and Safety of Dapagliflozin in Patients With Inadequately Controlled Type 1 Diabetes (the DEPICT-2 Study): 24-Week Results From a Randomized Controlled Trial
title_full Efficacy and Safety of Dapagliflozin in Patients With Inadequately Controlled Type 1 Diabetes (the DEPICT-2 Study): 24-Week Results From a Randomized Controlled Trial
title_fullStr Efficacy and Safety of Dapagliflozin in Patients With Inadequately Controlled Type 1 Diabetes (the DEPICT-2 Study): 24-Week Results From a Randomized Controlled Trial
title_full_unstemmed Efficacy and Safety of Dapagliflozin in Patients With Inadequately Controlled Type 1 Diabetes (the DEPICT-2 Study): 24-Week Results From a Randomized Controlled Trial
title_sort Efficacy and Safety of Dapagliflozin in Patients With Inadequately Controlled Type 1 Diabetes (the DEPICT-2 Study): 24-Week Results From a Randomized Controlled Trial
author_id_str_mv 5399f4c6e6a70f3608a084ddb938511a
author_id_fullname_str_mv 5399f4c6e6a70f3608a084ddb938511a_***_Steve Bain
author Steve Bain
author2 Chantal Mathieu
Paresh Dandona
Pieter Gillard
Peter Senior
Christoph Hasslacher
Eiichi Araki
Marcus Lind
Stephen C. Bain
Serge Jabbour
Niki Arya
Lars Hansen
Fredrik Thorén
Anna Maria Langkilde
Steve Bain
format Journal article
container_title Diabetes Care
container_volume 41
container_issue 9
container_start_page 1938
publishDate 2018
institution Swansea University
issn 0149-5992
1935-5548
doi_str_mv 10.2337/dc18-0623
college_str Faculty of Medicine, Health and Life Sciences
hierarchytype
hierarchy_top_id facultyofmedicinehealthandlifesciences
hierarchy_top_title Faculty of Medicine, Health and Life Sciences
hierarchy_parent_id facultyofmedicinehealthandlifesciences
hierarchy_parent_title Faculty of Medicine, Health and Life Sciences
department_str Swansea University Medical School - Medicine{{{_:::_}}}Faculty of Medicine, Health and Life Sciences{{{_:::_}}}Swansea University Medical School - Medicine
document_store_str 1
active_str 0
published_date 2018-09-01T03:54:41Z
_version_ 1763752732630450176
score 11.037581

Similar Items